The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Inhibition of SIRT2 promotes APP acetylation and ameliorates cognitive impairment in APP/PS1 transgenic mice
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Accordingly, SIRT2 inhibition or its genetic deletion has provided beneficial effects in different mouse models of Huntington's disease (Chopra et al., 2012;Luthi-Carter et al., 2010), Parkinson's disease (de Oliveira et al., 2017;Esteves et al., 2019;Sun et al., 2018); and Alzheimer's disease (AD) (Bai et al., 2022;Sola-Sevilla et al., 2023;Biella et al., 2016;Wang et al., 2020).”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Bai et al., 2022
In the citing paper
“Therefore, we propose that neuron SIRT2 deletion may be beneficial by reducing Aβ production (Bai et al., 2022;Wang et al., 2020), while microglia-specific SIRT2 deletion may impair Aβ degradation (Chen et al., 2023); present study), thereby exacerbating the pathology.”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Bai et al., 2022
In the citing paper
“Bai et al. (Bai et al., 2022) and Wang et al. (Wang et al., 2020) demonstrated that whole-body SIRT2 knockout or inhibition reduces amyloid pathology by shifting APP processing toward the non-amyloidogenic pathway, either through increased APP acetylation or inhibition of BACE1 activity.”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Bai et al., 2022
In the citing paper
“and its inhibition has shown beneficial effects in age-related neurodegenerative diseases such as AD (Bai et al., 2022;Sola-Sevilla et al., 2023;Biella et al., 2016;Wang et al., 2020;Sola-Sevilla and Puerta, 2024).”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Bai et al., 2022
In the citing paper
“These findings contrast with those previous studies showing that SIRT2 pharmacological inhibition or whole-body genetic deletion enhances learning and memory and reduces mortality and amyloid pathology in mouse models of AD (Bai et al., 2022;Sola-Sevilla et al., 2023;Biella et al., 2016;Wang et al., 2020).”
From Microglial SIRT2 deficiency aggravates cognitive decline and amyloid pathology in Alzheimer’s disease (2025) · cites this paper as Bai et al., 2022
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
Long, J. M., & Holtzman, D. M. (2019) · Cell · doi:10.1016/j.cell.2019.09.001 · Cited by 3,204
The acetylation of tau inhibits its function and promotes pathological tau aggregation
Cohen, T. J., Guo, J. L., Hurtado, D. E., Kwong, L. K., Mills, I. P., Trojanowski, J. Q., & Lee, V. M. Y. (2011) · Nature Communications · doi:10.1038/ncomms1255 · Cited by 724
Qin, W., Yang, T., Ho, L., Zhao, Z., Wang, J., Chen, L., Zhao, W., Thiyagarajan, M., MacGrogan, D., Rodgers, J. T., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602909200 · Cited by 626
Self-citationCritical role of acetylation in tau-mediated neurodegeneration and cognitive deficits
Min, S.-W., Chen, X., Tracy, T. E., Li, Y., Zhou, Y., Wang, C., Shirakawa, K., Minami, S. S., Defensor, E., Mok, S. A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3951 · Cited by 516
Self-citationSynaptic loss in Alzheimer's disease and other dementias
Hamos, J. E., DeGennaro, L. J., & Drachman, D. A. (1989) · Neurology · doi:10.1212/wnl.39.3.355 · Cited by 432
The epigenetics of aging and neurodegeneration
Lardenoije, R., Iatrou, A., Kenis, G., Kompotis, K., Steinbusch, H. W. M., Mastroeni, D., Coleman, P., Lemere, C. A., Hof, P. R., van den Hove, D. L. A., et al. (2015) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.05.002 · Cited by 381
Tracy, T. E., Sohn, P. D., Minami, S. S., Wang, C., Min, S.-W., Li, Y., Zhou, Y., Le, D., Lo, I., Ponnusamy, R., et al. (2016) · Neuron · doi:10.1016/j.neuron.2016.03.005 · Cited by 277
Self-citationSoluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation
Obregon, D., Hou, H., Deng, J., Giunta, B., Tian, J., Darlington, D., Shahaduzzaman, M., Zhu, Y., Mori, T., Mattson, M. P., et al. (2012) · Nature Communications · doi:10.1038/ncomms1781 · Cited by 192
An acetylation–phosphorylation switch that regulates tau aggregation propensity and function
Carlomagno, Y., Chung, D.-E. C., Yue, M., Castanedes-Casey, M., Madden, B. J., Dunmore, J., Tong, J., DeTure, M., Dickson, D. W., Petrucelli, L., et al. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.794602 · Cited by 143
Tackenberg, C., & Nitsch, R. M. (2019) · Molecular Brain · doi:10.1186/s13041-019-0447-2 · Cited by 56
Research works printed but not linked: 55
- Association, 2021, 2021 Alzheimer's disease facts and figures, Alzheimers Dement, 17, 327, 10.1002/alz.12328 · DOI · Paper page
- Bai, 2013, Dock3 interaction with a glutamate-receptor NR2D subunit protects neurons from excitotoxicity, Mol. Brain, 6, 22, 10.1186/1756-6606-6-22 · DOI
- Berson, 2018, Epigenetic regulation in neurodegenerative diseases, Trends Neurosci., 41, 587, 10.1016/j.tins.2018.05.005 · DOI · Paper page
- Biella, 2016, Sirtuin 2 inhibition improves cognitive performance and acts on amyloid-β protein precursor processing in two Alzheimer’s disease mouse models, J. Alzheim. Dis., 53, 1193, 10.3233/JAD-151135 · DOI · Paper page
- Brouillette, 2012, Neurotoxicity and memory deficits induced by soluble low-molecular-weight amyloid-β1–42 oligomers are revealed in vivo by using a novel animal model, J. Neurosci., 32, 7852, 10.1523/JNEUROSCI.5901-11.2012 · DOI · Paper page
- Brunet, 2014, Epigenetics of aging and aging-related disease, J. Gerontol. A. Biol. Sci. Med. Sci., 69, S17, 10.1093/gerona/glu042 · DOI · Paper page
- Chen, 2015, The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson’s disease but not amyotrophic lateral sclerosis and cerebral ischemia, PLoS One, 10, e0116919, 10.1371/journal.pone.0116919 · DOI
- Chopra, 2012, The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington’s disease mouse models, Cell Rep., 2, 1492, 10.1016/j.celrep.2012.11.001 · DOI · Paper page
- Cook, 2014, Acetylation of the KXGS motifs in tau is a critical determinant in modulation of tau aggregation and clearance, Hum. Mol. Genet., 23, 104, 10.1093/hmg/ddt402 · DOI · Paper page
- De Oliveira, 2017, The mechanism of sirtuin 2–mediated exacerbation of alpha-synuclein toxicity in models of Parkinson disease, PLoS Biol., 15, e2000374, 10.1371/journal.pbio.2000374 · DOI · Paper page
- Deacon, 2006, Assessing nest building in mice, Nat. Protoc., 1, 1117, 10.1038/nprot.2006.170 · DOI · Paper page
- Deyts, 2019, APP-mediated signaling prevents memory decline in Alzheimer’s disease mouse model, Cell Rep., 27, 1345, 10.1016/j.celrep.2019.03.087 · DOI
- Deyts, 2016, APP receptor? To be or not to be, Trends Pharmacol. Sci., 37, 390, 10.1016/j.tips.2016.01.005 · DOI
- Dickey, 2005, Dysregulation of Na+/K+ ATPase by amyloid in APP+ PS1 transgenic mice, BMC Neurosci., 6, 7, 10.1186/1471-2202-6-7 · DOI
- Esteves, 2019, Acetylation as a major determinant to microtubule-dependent autophagy: relevance to Alzheimer's and Parkinson disease pathology, Biochim. Biophys. Acta, Mol. Basis Dis., 1865, 2008, 10.1016/j.bbadis.2018.11.014 · DOI · Paper page
- Frye, 2000, Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins, Biochem. Biophys. Res. Commun., 273, 793, 10.1006/bbrc.2000.3000 · DOI · Paper page
- Goodman, 1994, Secreted forms of β-amyloid precursor protein protect hippocampal neurons against amyloid β-peptide-induced oxidative injury, Exp. Neurol., 128, 1, 10.1006/exnr.1994.1107 · DOI · Paper page
- Gräff, 2013, The potential of HDAC inhibitors as cognitive enhancers, Annu. Rev. Pharmacol. Toxicol., 53, 311, 10.1146/annurev-pharmtox-011112-140216 · DOI · Paper page
- Gralle, 2009, Neuroprotective secreted amyloid precursor protein acts by disrupting amyloid precursor protein dimers, J. Biol. Chem., 284, 15016, 10.1074/jbc.M808755200 · DOI
- Habib, 2017, Restoring soluble amyloid precursor protein α functions as a potential treatment for Alzheimer's disease, J. Neurosci. Res., 95, 973, 10.1002/jnr.23823 · DOI
- Haigis, 2010, Mammalian sirtuins: biological insights and disease relevance, Annu. Rev. Pathol., 5, 253, 10.1146/annurev.pathol.4.110807.092250 · DOI · Paper page
- Henry, 2010, Mechanisms of disease Alzheimer’s disease, N. Engl. J. Med., 362, 329, 10.1056/NEJMra0909142 · DOI · Paper page
- Jayasena, 2016, Application of targeted mass spectrometry for the quantification of sirtuins in the central nervous system, Sci. Rep., 6, 35391, 10.1038/srep35391 · DOI · Paper page
- Jeong, 2009, Acetylation targets mutant huntingtin to autophagosomes for degradation, Cell, 137, 60, 10.1016/j.cell.2009.03.018 · DOI · Paper page
- Kaden, 2008, Homophilic interactions of the amyloid precursor protein (APP) ectodomain are regulated by the loop region and affect β-secretase cleavage of APP, J. Biol. Chem., 283, 7271, 10.1074/jbc.M708046200 · DOI
- Kar, 2003, Repeat motifs of tau bind to the insides of microtubules in the absence of taxol, EMBO J., 22, 70, 10.1093/emboj/cdg001 · DOI · Paper page
- Khalifa, 2010, What is the role of amyloid precursor protein dimerization?, Cell Adh. Migr., 4, 268, 10.4161/cam.4.2.11476 · DOI
- Kim, 2011, SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity, Cancer Cell, 20, 487, 10.1016/j.ccr.2011.09.004 · DOI · Paper page
- Langley, 2005, Remodeling chromatin and stress resistance in the central nervous system: histone deacetylase inhibitors as novel and broadly effective neuroprotective agents, Curr. Drug Targets CNS Neurol. Disord., 4, 41, 10.2174/1568007053005091 · DOI · Paper page
- Lee, 2014, Cilostazol suppresses β-amyloid production by activating a disintegrin and metalloproteinase 10 via the upregulation of SIRT1-coupled retinoic acid receptor-β, J. Neurosci. Res., 92, 1581, 10.1002/jnr.23421 · DOI
- Manjula, 2021, SIRT1 and SIRT2 activity control in neurodegenerative diseases, Front. Pharmacol., 11, 585821, 10.3389/fphar.2020.585821 · DOI · Paper page
- Marques, 2012, Epigenetic regulation of BACE1 in Alzheimer’s disease patients and in transgenic mice, Neuroscience, 220, 256, 10.1016/j.neuroscience.2012.06.029 · DOI
- Maxwell, 2011, The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS, Hum. Mol. Genet., 20, 3986, 10.1093/hmg/ddr326 · DOI · Paper page
- Meziane, 1998, Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice, Proc. Natl. Acad. Sci. U S A, 95, 12683, 10.1073/pnas.95.21.12683 · DOI · Paper page
- Michan, 2007, Sirtuins in mammals: insights into their biological function, Biochem. J., 404, 1, 10.1042/BJ20070140 · DOI · Paper page
- Min, 2010, Acetylation of tau inhibits its degradation and contributes to tauopathy, Neuron, 68, 801, 10.1016/j.neuron.2010.11.013 · DOI
- Min, 2018, SIRT1 deacetylates tau and reduces pathogenic tau spread in a mouse model of tauopathy, J. Neurosci., 38, 3680, 10.1523/JNEUROSCI.2369-17.2018 · DOI
- North, 2003, The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase, Mol. Cell, 11, 437, 10.1016/S1097-2765(03)00038-8 · DOI · Paper page
- Outeiro, 2007, Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease, Science, 317, 516, 10.1126/science.1143780 · DOI · Paper page
- Polito, 2013, The SIRT2 polymorphism rs10410544 and risk of Alzheimer’s disease in two Caucasian case–control cohorts, Alzheimers Dement., 9, 392, 10.1016/j.jalz.2012.02.003 · DOI
- Satoh, 2013, Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH, Cell Metabol., 18, 416, 10.1016/j.cmet.2013.07.013 · DOI · Paper page
- Satoh, 2017, The brain, sirtuins, and ageing, Nat. Rev. Neurosci., 18, 362, 10.1038/nrn.2017.42 · DOI · Paper page
- Scheuermann, 2001, Homodimerization of amyloid precursor protein and its implication in the amyloidogenic pathway of Alzheimer's disease, J. Biol. Chem., 276, 33923, 10.1074/jbc.M105410200 · DOI · Paper page
- Selkoe, 1998, The cell biology of β-amyloid precursor protein and presenilin in Alzheimer's disease, Trends Cell Biol., 8, 447, 10.1016/S0962-8924(98)01363-4 · DOI · Paper page
- Sierksma, 2016, Fluoxetine treatment induces seizure behavior and premature death in APPswe/PS1dE9 mice, J. Alzheim. Dis., 51, 677, 10.3233/JAD-151066 · DOI
- Silva, 2017, Mitochondrial metabolism power SIRT2-dependent deficient traffic causing Alzheimer’s-disease related pathology, Mol. Neurobiol., 54, 4021, 10.1007/s12035-016-9951-x · DOI
- Soba, 2005, Homo-and heterodimerization of APP family members promotes intercellular adhesion, EMBO J., 24, 3624, 10.1038/sj.emboj.7600824 · DOI · Paper page
- Taylor, 2008, Endogenous secreted amyloid precursor protein-α regulates hippocampal NMDA receptor function, long-term potentiation and spatial memory, Neurobiol. Dis., 31, 250, 10.1016/j.nbd.2008.04.011 · DOI · Paper page
- Tsukamoto, 1997, Silencing factors participate in DNA repair and recombination in Saccharomyces cerevisiae, Nature, 388, 900, 10.1038/42288 · DOI · Paper page
- Wang, 2013, Metabolic stress modulates Alzheimer’s β-secretase gene transcription via SIRT1-PPARγ-PGC-1 in neurons, Cell Metabol., 17, 685, 10.1016/j.cmet.2013.03.016 · DOI · Paper page
- Wang, 2020, RTN4B-mediated suppression of Sirtuin 2 activity ameliorates β-amyloid pathology and cognitive impairment in Alzheimer's disease mouse model, Aging Cell, 19, e13194, 10.1111/acel.13194 · DOI · Paper page
- Wei, 2014, The SIRT2 polymorphism rs10410544 and risk of Alzheimer’s disease: a meta-analysis, NeuroMolecular Med., 16, 448, 10.1007/s12017-014-8291-0 · DOI
- Yi, 2021, The deacetylation-phosphorylation regulation of SIRT2-SMC1A axis as a mechanism of antimitotic catastrophe in early tumorigenesis, Sci. Adv., 7, eabe5518, 10.1126/sciadv.abe5518 · DOI
- Zhang, 2019, Phosphorylation signaling in APP processing in Alzheimer’s disease, Int. J. Mol. Sci., 21, 209, 10.3390/ijms21010209 · DOI
- Zheng, 2006, The amyloid precursor protein: beyond amyloid, Mol. Neurodegener., 1, 5, 10.1186/1750-1326-1-5 · DOI
Cited by
Li, X., Tang, X., Zeng, J., Duan, L., Hou, Z., Li, L., Guo, Y., Chai, C., Liu, J., Wang, Y., et al. (2026) · Cell · doi:10.1016/j.cell.2025.12.020 · Cited by 32
Self-citationSola-Sevilla, N., Garmendia-Berges, M., Aleixo, M., Mera-Delgado, M., Solas, M., Tordera, R. M., García-Carracedo, L., Expósito, S., Anaya-Cubero, E., Fernández-Irigoyen, J., et al. (2025) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2025.06.016 · Cited by 5
Metadata
- Authors
- Bai, N., Li, N., Cheng, R., Guan, Y., Zhao, X., Song, Z., Xu, H., Yi, F., Jiang, B., Li, X., Wu, X., Jiang, C., Zhou, T., Guo, Q., Guo, W., Feng, Y., Wang, Z., Ma, M., Yu, Y., Wang, Z., Zhang, S., Wang, C., Zhao, W., Liu, S., Song, X., Liu, H., & Cao, L.
- Venue
- Cell Reports
- Publisher
- Elsevier BV
- Published
- 2022-07
- Volume
- 40
- Issue
- 2
- Pages
- 111062
- ISSN
- 2211-1247
- Cited by
- 61
- References
- 10
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Funders
- National Natural Science Foundation of China (81902859, 81770001, 82073089, 82000827, 82030091)
- National Key Research and Development Program of China
- Fudan University
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibition of SIRT2 promotes APP acetylation and ameliorates cognitive impairment in APP/PS1 transgenic mice. https://app.cochat.ai/papers/10.1016/j.celrep.2022.111062
- The paper
- Bai, N., Li, N., Cheng, R., Guan, Y., Zhao, X., Song, Z., Xu, H., Yi, F., Jiang, B., Li, X., Wu, X., Jiang, C., Zhou, T., Guo, Q., Guo, W., Feng, Y., Wang, Z., Ma, M., Yu, Y., . . . Cao, L. (2022). Inhibition of SIRT2 promotes APP acetylation and ameliorates cognitive impairment in APP/PS1 transgenic mice. Cell Reports. https://doi.org/10.1016/j.celrep.2022.111062
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.